CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for use in the treatment of Aspergillosis & Mucor mycosis Indication of CRESEMBA Invasive aspergillosis Invasive mucormycosis Contraindications of CRESEMBA Hypersensitivity to CRESEMBA Coadministration with strong CYP3A4 inhibitors, such as ketoconazole or high-dose ritonavir Coadministration with strong CYP3A4 inducers, such as rifampin, carbamazepine, St. John’s wort, or long acting barbiturates Use in patients with familial short QT syndrome Warning & Precautions for Use of CRESEMBA Hepatic Adverse Drug Reactions: Serious hepatic reactions have been reported. Evaluate liver-related laboratory tests at the start and during the course of CRESEMBA therapyInfusion-related reactions were reported during intravenous administration of CRESEMBA. Discontinue the infusion if these reactions occur Hypersensitivity Reactions: Serious hypersensitivity and severe skin reactions, such as anaphylaxi...